N,N'-Bis[tert-butoxycarbonyl]-L-cystein
|
|
|
- CAS-Nr.
- 10389-65-8
- Bezeichnung:
- N,N'-Bis[tert-butoxycarbonyl]-L-cystein
- Englisch Name:
- (BOC-CYS-OH)2
- Synonyma:
- BOC-L-CYSTINE;(BOC-CYS-OH)2;(Boc-L-Cys-OH)2;BIS-BOC-L-CYSTINE;N N-BOC-L-CYSTEINE;(Boc-CYS-OH)2, 〉98%;N,N'-Bis-Boc-cystine;N,N’-di-Boc-L-cystine;N,N'-Bis-Boc-L-cystine;BOC-L-CYSTINE extrapure
- CBNumber:
- CB5748884
- Summenformel:
- C16H28N2O8S2
- Molgewicht:
- 440.53
- MOL-Datei:
- 10389-65-8.mol
|
N,N'-Bis[tert-butoxycarbonyl]-L-cystein Eigenschaften
- Schmelzpunkt:
- 140-145 °C
- Siedepunkt:
- 627.4±55.0 °C(Predicted)
- Dichte
- 1.313±0.06 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,2-8°C
- Löslichkeit
- Acetic Acid (Sparingly) DMSO (Slightly, Sonicated), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 3.17±0.10(Predicted)
- Farbe
- White to Off-White
- Optische Aktivität
- [α]20/D 120±3°, c = 2% in acetic acid
- BRN
- 2229312
N,N'-Bis[tert-butoxycarbonyl]-L-cystein Chemische Eigenschaften,Einsatz,Produktion Methoden
S-Sätze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Chemische Eigenschaften
White powder
Verwenden
N,N''-Di-BOC-L-cystine, can be used for the synthesis of Toll-Like Receptor-2 agonists lipopeptides, which are potential vaccine adjuvants.
läuterung methode
Crystallise the cystine derivative from EtOAc by adding hexane [Ferraro pKEst Biochemical Preparations 13 39 1971].
N,N'-Bis[tert-butoxycarbonyl]-L-cystein Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N,N'-Bis[tert-butoxycarbonyl]-L-cystein Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 138)Lieferanten
10389-65-8(N,N'-Bis[tert-butoxycarbonyl]-L-cystein)Verwandte Suche:
- N,N’-di-Boc-L-cystine
- N,N'-Bis-Boc-L-cystine
- (Boc-Cys-OH)2
- (Boc-Cys-OH)2 >=98% (CE)
- N,N''-Bis-(tert-butoxycarbonyl)-L-cystine
- (Boc-L-Cys-OH)2
- N-alpha-t-Butyloxycarbonyl-L-cystine
- BOC-L-CYSTINE extrapure
- Nalpha,Nalpha'-di(tert-butoxycarbonyl)-L-cystine
- 3,3'-Dithiobis[N-(tert-butoxycarbonyl)-L-alanine]
- N,N'-Bis(tert-butoxycarbonyl)cystine
- N,N'-Bis[(tert-butyloxy)carbonyl]-L-cystine
- N,N'-Bis-Boc-cystine
- BIS-BOC-L-CYSTINE
- BOC-L-CYSTINE
- (BOC-CYS-OH)2
- N-ALPHA,N-ALPHA-BIS-T-BUTYLOXYCARBONYL-L-CYSTINE
- N-ALPHA,N-ALPHA'-DI-BOC-L-CYSTINE
- N,N'-BIS-T-BOC-L-CYSTINE
- N N-BOC-L-CYSTEINE
- (Boc-Cys-OH)2 (Disulfide bond)
- Nα,Nα'-Bis-Boc-L-cystine≥ 98% (HPLC)
- N,N'-bis[tert-butoxycarbonyl]-L-cysteine
- ((Tert-Butoxy)Carbonyl Cys-OH)2
- (2R)-2-{[(tert-butoxy)carbonyl]amino}-3-{[(2R)-2-{[(tert-butoxy)carbonyl]amino}-2-carboxyethyl]disulfanyl}propanoic acid
- (Boc-CYS-OH)2, 〉98%
- 3-[[2-carboxy-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]ethyl]disulfanyl]-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]propanoic acid
- L-Cystine, N,N'-bis[(1,1-dimethylethoxy)carbonyl]-
- (BOC-CYS-OH)2 USP/EP/BP
- 10389-65-8
- C16H28N2O8S2
- Cysteine/Cystine
- Peptide Synthesis
- Specialty Synthesis
- Amino Acid Derivatives
- Amino Acids
